vs
Side-by-side financial comparison of Aeluma, Inc. (ALMU) and Q32 Bio Inc. (QTTB). Click either name above to swap in a different company.
Q32 Bio Inc. is the larger business by last-quarter revenue ($1.9M vs $1.3M, roughly 1.5× Aeluma, Inc.). Q32 Bio Inc. runs the higher net margin — 2991.2% vs -145.7%, a 3136.9% gap on every dollar of revenue.
Aeluma, Inc. is a U.S.-headquartered technology firm focused on the design, development, and production of high-performance optoelectronic components and semiconductor products. Its core offerings include photonic sensors and laser diodes, serving the LiDAR, 5G/6G communication, industrial sensing, and automotive markets across North America and the Asia-Pacific region.
Q32 Bio Inc. is a clinical-stage biotechnology company focused on developing targeted antibody-based immunotherapies for autoimmune disorders, inflammatory conditions and rare immunological diseases with unmet medical needs, operating primarily across North America and European markets.
ALMU vs QTTB — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3M | $1.9M |
| Net Profit | $-1.9M | $57.7M |
| Gross Margin | 27.8% | — |
| Operating Margin | -163.6% | — |
| Net Margin | -145.7% | 2991.2% |
| Revenue YoY | -21.1% | — |
| Net Profit YoY | 36.0% | 506.9% |
| EPS (diluted) | $-0.11 | $4.70 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.3M | $1.9M | ||
| Q3 25 | $1.4M | $-220.0K | ||
| Q2 25 | — | $-284.0K | ||
| Q1 25 | — | $-371.0K | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
| Q4 25 | $-1.9M | $57.7M | ||
| Q3 25 | $-1.5M | $-7.4M | ||
| Q2 25 | — | $-9.5M | ||
| Q1 25 | — | $-11.0M | ||
| Q4 24 | — | $-14.2M | ||
| Q3 24 | — | $-17.6M | ||
| Q2 24 | — | $-17.0M | ||
| Q1 24 | — | $1.0M |
| Q4 25 | 27.8% | — | ||
| Q3 25 | 49.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -163.6% | — | ||
| Q3 25 | -116.1% | 3444.1% | ||
| Q2 25 | — | 3229.2% | ||
| Q1 25 | — | 3296.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -145.7% | 2991.2% | ||
| Q3 25 | -107.8% | 3358.6% | ||
| Q2 25 | — | 3341.2% | ||
| Q1 25 | — | 2973.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-0.11 | $4.70 | ||
| Q3 25 | $-0.09 | $-0.60 | ||
| Q2 25 | — | $-0.78 | ||
| Q1 25 | — | $-0.90 | ||
| Q4 24 | — | $2.63 | ||
| Q3 24 | — | $-1.46 | ||
| Q2 24 | — | $-1.42 | ||
| Q1 24 | — | $-6.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $38.6M | $48.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $40.8M | $42.0M |
| Total Assets | $42.6M | $61.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $38.6M | $48.3M | ||
| Q3 25 | $25.9M | $49.0M | ||
| Q2 25 | — | $54.8M | ||
| Q1 25 | — | $65.5M | ||
| Q4 24 | — | $78.0M | ||
| Q3 24 | — | $89.1M | ||
| Q2 24 | — | $97.7M | ||
| Q1 24 | — | $115.5M |
| Q4 25 | $40.8M | $42.0M | ||
| Q3 25 | $40.9M | $-18.4M | ||
| Q2 25 | — | $-12.2M | ||
| Q1 25 | — | $-4.0M | ||
| Q4 24 | — | $5.7M | ||
| Q3 24 | — | $18.3M | ||
| Q2 24 | — | $33.5M | ||
| Q1 24 | — | $48.8M |
| Q4 25 | $42.6M | $61.8M | ||
| Q3 25 | $42.7M | $57.8M | ||
| Q2 25 | — | $66.1M | ||
| Q1 25 | — | $79.1M | ||
| Q4 24 | — | $92.3M | ||
| Q3 24 | — | $104.5M | ||
| Q2 24 | — | $124.2M | ||
| Q1 24 | — | $152.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-251.0K | $-6.2M |
| Free Cash FlowOCF − Capex | $-282.0K | — |
| FCF MarginFCF / Revenue | -22.2% | — |
| Capex IntensityCapex / Revenue | 2.4% | — |
| Cash ConversionOCF / Net Profit | — | -0.11× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-251.0K | $-6.2M | ||
| Q3 25 | $-815.0K | $-4.2M | ||
| Q2 25 | — | $-10.7M | ||
| Q1 25 | — | $-12.5M | ||
| Q4 24 | — | $-11.4M | ||
| Q3 24 | — | $-19.5M | ||
| Q2 24 | — | $-22.2M | ||
| Q1 24 | — | $-14.6M |
| Q4 25 | $-282.0K | — | ||
| Q3 25 | $-1.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-11.4M | ||
| Q3 24 | — | $-19.6M | ||
| Q2 24 | — | $-22.2M | ||
| Q1 24 | — | — |
| Q4 25 | -22.2% | — | ||
| Q3 25 | -74.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 2.4% | — | ||
| Q3 25 | 15.2% | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | -0.11× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -14.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
